EI DuPont de Nemours & Co. Earnings: Will Its Transformation Bring Growth?

On Thursday, DuPont (NYSE: DD  ) will release its quarterly report, and shareholders have been pleased about the transformation that the chemical giant has made in its business model. Following the lead of Monsanto (NYSE: MON  ) in shifting its focus toward agriculture, DuPont hopes to get the same benefits that Monsanto and Dow Chemical (NYSE: DOW  ) have reaped from divesting slower-growth businesses in favor of the higher growth available from the ag industry.

DuPont has a long history as an industrial chemical giant, having produced plastics, photovoltaic materials, and a wide range of performance chemicals for a vast array of customers. But more recently DuPont has chosen to cast itself more heavily in the agricultural vein, producing seeds, pesticides, and other useful products for farmers to use to boost their crop yields. Investors are excited about the potential of this business, but will it pay off for DuPont as well as it has for Monsanto? Let's take an early look at what's been happening with DuPont over the past quarter and what we're likely to see in its report.


Source: USDA, Natural Resources Conservation Service.

Stats on DuPont

Analyst EPS Estimate

$1.59

Change From Year-Ago EPS

1.9%

Revenue Estimate

$10.45 billion

Change From Year-Ago Revenue

0.4%

Earnings Beats in Past 4 Quarters

4

Source: Yahoo! Finance.

Can DuPont earnings keep growing?
Analysts have had deeply mixed views in recent months on DuPont earnings, slashing their first-quarter estimates by 10% but boosting their projections for 2015 full-year earnings by $0.34 per share. The stock has held up well, rising 5% since early January.

DuPont's fourth-quarter earnings report shows some of the pressure that the chemical giant is under to produce stronger growth. Even though the company's earnings per share almost tripled from the year-ago quarter, investors focused instead on tepid growth forecasts for 2014 that suggested revenue could rise by just 4%. Still, DuPont has already correctly identified the problem, with 14% growth from DuPont's ag business showing the greater potential it has compared to slower-growth areas like its performance chemicals segment.

DuPont has made efforts to enhance its value to the farming community. In early February, DuPont announced a deal with DTN/The Progressive Farmer, an information-provider that will let DuPont send precise weather and crop-market data to its customers in order to help them tailor their growing strategies for maximum results. Given that Monsanto did a similar deal late last year, DuPont clearly sees the need to woo customers by providing value-added services.

Yet DuPont and its peers face the ongoing challenge of negative sentiment toward genetically modified organisms. Risk expert Nassim Taleb has recently taken up the mantle of anti-GMO protest, arguing that the threat to the world's ecosystem that GMOs pose outweighs the potential benefits from their use. Taleb is well-known for his emphasis on low probability, high significance events, and given the tendency for GMO traits to spread, the lack of control that DuPont and its peers have over their products introduces risk levels that Taleb and many others are unwilling to take. If enough people get behind anti-GMO moves, it could crush DuPont's new strategy in its infancy.

Moreover, competitive pressures will loom large on DuPont's growth. Monsanto has had a huge head-start in the space and has managed to sign cross-licensing agreements with DuPont and many of their rivals. Like DuPont, Dow Chemical is trying to shift its focus more toward agriculture, but Monsanto's market share is holding both companies back.

In the DuPont earnings report, watch to see how the company's agricultural transition progresses. With all eyes on DuPont's plan to spin off its performance chemicals business to its shareholders, DuPont will become even more dependent on agriculture in the near future -- for good or ill.

3 stocks poised to be multi-baggers
The one sure way to get wealthy is to invest in a groundbreaking company that goes on to dominate a multibillion-dollar industry. Our analysts have found multi-bagger stocks time and again. And now they think they've done it again with three stock picks that they believe could generate the same type of phenomenal returns. They've revealed these picks in a new free report that you can download instantly by clicking here now.

Click here to add DuPont to My Watchlist, which can find all of our Foolish analysis on it and all your other stocks.


Read/Post Comments (2) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On April 15, 2014, at 2:46 PM, funfundvierzig wrote:

    For sixteen years since 1998, DuPont's two bumbling über bosses, former Chief Chad O. Holliday, Jr, and his protege, current Chieftess Ellen J. Kullman, have been executing this illogical and flawed business model:

    SHRINKAGE equals GROWTH

    It doesn't and hasn't for DuPont. Once the largest and most powerful chemical enterprise for most of the 20th century, DuPont had shrunk and declined to number 10 by 2008 amongst global chemical enterprises in revenues.

    Now with Ms. Kullman's announced strategy to dump her DuPont Performance Chemicals in a year, the annual revenues of this shriveling conglomerate will fall by a whopping 20%, circa $7 billion. Sorry, but Shrinkage does not engender Growth.

    In the meantime, the lagging DuPont will play second fiddle to Monsanto in seeds, and third fiddle to Syngenta and Bayer in crop protection and ag chemicals.

    Merely the opinion of one individual retail investor...funfun..

  • Report this Comment On April 25, 2014, at 1:12 PM, QD379X wrote:

    Any comments regarding DuPont's venture into

    enzymes and industrial applications?

Add your comment.

DocumentId: 2916156, ~/Articles/ArticleHandler.aspx, 7/22/2014 8:34:02 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement